Site-specific modification and PEGylation of pharmaceutical proteins mediated by transglutaminase
- 16 August 2007
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 60 (1) , 13-28
- https://doi.org/10.1016/j.addr.2007.06.015
Abstract
No abstract availableKeywords
This publication has 134 references indexed in Scilit:
- Characterization of Molecular Recognition Features, MoRFs, and Their Binding PartnersJournal of Proteome Research, 2007
- On the size of the active site in proteases. I. PapainPublished by Elsevier ,2005
- The multifaceted role of transglutaminase in neurodegeneration: Review articleAmino Acids, 2004
- Therapeutic strategies for human amyloid diseasesNature Reviews Drug Discovery, 2002
- Probing the conformational state of apomyoglobin by limited proteolysis 1 1Edited by P. E. WrightJournal of Molecular Biology, 1997
- Enhanced susceptibility to transglutaminase reaction of α-lactalbumin in the molten globule stateBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1996
- The Crystal Structure of Affinity-matured Human Growth Hormone at 2 Å ResolutionJournal of Molecular Biology, 1994
- Characterization of “native” apomyoglobin by molecular dynamics simulationJournal of Molecular Biology, 1992
- High-resolution study of the three-dimensional structure of horse heart metmyoglobinJournal of Molecular Biology, 1990
- Correlation among sites of limited proteolysis, enzyme accessibility and segmental mobilityFEBS Letters, 1987